Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Biochimica Et Biophysica Acta. Reviews on Cancer|January 23, 2018
Chaperoning the guardian of the genome. The two-faced role of molecular chaperones in p53 tumor suppressor actionBartosz Wawrzynow, Alicja Zylicz, Maciej ZyliczThe Journal of Biological Chemistry|September 13, 2007
MDM2 chaperones the p53 tumor suppressorBartosz Wawrzynow, Alicja Zylicz, Maura Wallace, et al.Cancers|September 28, 2021
Chemotherapy of HER2- and MDM2-Enriched Breast Cancer Subtypes Induces Homologous Recombination DNA Repair and ChemoresistanceMarcin Herok, Bartosz Wawrzynow, Marta J Maluszek, et al.Plos One|December 20, 2012
Molecular mechanism of mutant p53 stabilization: the role of HSP70 and MDM2Milena Wiech, Maciej B Olszewski, Zuzanna Tracz-Gaszewska, et al.The FEBS Journal|August 30, 2008
ATP stimulates MDM2-mediated inhibition of the DNA-binding function of E2F1Craig Stevens, Susanne Pettersson, Bartosz Wawrzynow, et al.Journal of Chemical Biology|July 2, 2009
Regulation of the E3 ubiquitin ligase activity of MDM2 by an N-terminal pseudo-substrate motifErin G Worrall, Bartosz Wawrzynow, Liam Worrall, et al.The Journal of Biological Chemistry|February 4, 2009
A function for the RING finger domain in the allosteric control of MDM2 conformation and activityBartosz Wawrzynow, Susanne Pettersson, Alicja Zylicz, et al.The Journal of Biological Chemistry|August 7, 2010
ATP binding to Hsp90 is sufficient for effective chaperoning of p53 proteinDawid Walerych, Malgorzata Gutkowska, Marcin P Klejman, et al.The Journal of Biological Chemistry|September 11, 2004
Hsp90 chaperones wild-type p53 tumor suppressor proteinDawid Walerych, Grzegorz Kudla, Malgorzata Gutkowska, et al.Oncotarget|November 16, 2017
Molecular chaperones in the acquisition of cancer cell chemoresistance with mutated <i>TP53</i> and MDM2 up-regulationZuzanna Tracz-Gaszewska, Marta Klimczak, Przemyslaw Biecek, et al.Pageof 1